Zydus acquires derma brand Melgain from Issar Pharma

Posted on:08 Aug 2016 18:30:17
Zydus acquires derma brand Melgain from Issar Pharma
08 August 2016 Current Affairs: Ahmedabad-headquartered Zydus Group has acquiredMelgain brand from Hyderabad based Issar Pharma for an undisclosed sum that would marketed in India by Liva Healthcare, a speciality division of the Group catering to the dermatological segment.

Zydus is currently the leader in the skin de-pigmentation segment and the acquisition of Melgain marks its foray into the re-pigmentation segment.

Dermatology has been a core focus segment and we have been working with the medical fraternity to serve patient needs better. I believe that this acquisition will strengthen our portfolio of derma brands and will leverage our equity in this key segment.

Zydus also has an option to launch this product in other global markets where it is not available. Melgain is used for the treatment of Vitiligo, a chronic skin condition characterized by portions of the skin losing their pigment. It occurs when skin pigment cells die or are unable to function. Though the reason for the onset of the condition is not known, the most widely accepted view is that the depigmentation occurs because Vitiligo is an autoimmune disease — a disease in which a person's immune system reacts against the body's own organs or tissues.

Nearly 15-20 million people in India are estimated to be suffering from this condition. Half of those affected show the disorder before age 20, though most develop it before age 40.

Monthly Current Affairs

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs December 2017

18 DECEMBER
NEWS
17 DECEMBER
NEWS
16 DECEMBER
NEWS
15 DECEMBER
NEWS

Current Affairs November 2017

30 NOVEMBER
NEWS
29 NOVEMBER
NEWS
28 NOVEMBER
NEWS
27 NOVEMBER
NEWS

Current Affairs October 2017

31 OCTOBER
NEWS
30 OCTOBER
NEWS
29 OCTOBER
NEWS
28 OCTOBER
NEWS